Reconstructive surgery (after mastectomy for cancer) is medically necessary, often covered by insurance. Cosmetic surgery (augmentation for size or shape) is elective, paid out‑of‑pocket. The breast implants market forecast shows that reconstructive surgery is the largest end‑use segment, but cosmetic surgery is the fastest‑growing. Why? Because breast augmentation is now the #1 cosmetic surgery worldwide, driven by social media and celebrity culture.
What's the difference? Reconstructive patients often need more complex procedures (flap surgery, nipple reconstruction) and may have radiation‑damaged skin. The breast implants market analysis notes that the fastest‑growing surface texture is smooth, as textured implants fall out of favour due to cancer risk.
But cosmetic surgery isn't without risk: capsular contracture (scar tissue tightening around the implant), rupture, and the need for revision surgery (10‑15% within 10 years).
The bottom line: if you're considering breast implants, do your research. Reconstructive patients should seek a surgeon who specialises in post‑mastectomy reconstruction. Cosmetic patients should be realistic about risks and costs.
What is the current size of the breast implants market?
$3.47 billion in 2024. Full report: breast implants market report.
Which implant type dominates?
Silicone implants. See the breast implants market analysis.
Fastest‑growing implant type?
Saline implants. Check breast implants market trends.
What is the projected market size by 2035?
$5.997 billion. Forecast in breast implants market forecast.
Who are the key players globally?
Allergan, Mentor, Sientra, GC Aesthetics. The breast implants market research has full competitive landscape.